Case Studies2020-11-19T22:10:23-08:00

Case Studies

  • Aurora Cannabis

Aurora Cannabis Reports Q1 FY2026 Financial Results

EDMONTON – Aurora Cannabis Inc. (ACB), a leading Canadian Cannabis producer, announced its financial and operational results for the first quarter of fiscal 2026, ending June 30, 2025, showcasing robust growth in its medical Cannabis ...

Week In Review: Cannabis & Psychedelics Industry Highlights

LOS ANGELES - Critical compliance issues, market exits, and clinical and regulatory breakthroughs shaped a turbulent week for cannabis and psychedelics businesses. Cannabis Industry Highlights 1.Cresco Labs Exits California, Refocuses on Profitability Cresco Labs confirmed ...

  • Aurora Cannabis

Aurora Cannabis Reports Q1 FY2026 Financial Results

EDMONTON – Aurora Cannabis Inc. (ACB), a leading Canadian Cannabis producer, announced its financial and operational results for the first quarter of fiscal 2026, ending June 30, 2025, showcasing robust growth in its medical Cannabis ...

Humboldt Family Farms: Terroir and Cannabis

The concept of terroir, traditionally rooted in French viticulture, refers to the unique set of environmental factors that influence the growth and characteristics of a crop. While usually associated with wine, the application of terroir ...

MariMed Reports Q1 2025 Financial Results

LOS ANGELES- MariMed Inc. a multi-state cannabis operator, reported its financial results for the first quarter ended March 31, 2025. Financial Overview Revenue: $38.0 million, a slight increase from $37.9 million in Q1 2024. Gross ...

Cannabis in Psychedelic Therapy: Potential and Precautions

LOS ANGELES- The integration of cannabis into psychedelic-assisted psychotherapy is gaining attention as a potential treatment for various mental health conditions, including post-traumatic stress disorder (PTSD), depression, and anxiety. This approach involves administering cannabis in ...

Cybin Partners with Thermo Fisher for U.S. Manufacturing

LOS ANGELES- Cybin Inc. a neuropsychiatry company, has announced a collaboration with Thermo Fisher Scientific to support the Phase 3 clinical supply and potential commercial manufacturing of CYB003, its proprietary deuterated psilocin analog, for the ...

Rubicon Organics Appoints Glen Ibbott as Interim CFO

LOS ANGELES- Rubicon Organics Inc.  a Canadian producer of certified organic cannabis products, has appointed Glen Ibbott as Interim Chief Financial Officer, effective May 15, 2025. This leadership change follows the departure of Janis Risbin ...

TILT Holdings Reports First Quarter 2025 Financial Results

LOS ANGELES- TILT Holdings Inc. announced its financial results for the first quarter ended March 31, 2025, reflecting a year-over-year revenue decline and continued strategic realignment towards its Jupiter inhalation technology business. Financial Performance The ...

High-Paying Roles in the Cannabis Industry

LOS ANGELES- As the cannabis industry continues its expansion across the United States, it presents a variety of high-paying career opportunities. Positions such as cultivation directors, compliance officers, and extraction technicians are in demand, offering ...

  • Fast Buds - German cannabis legalisation

German Medical Cannabis Market Sees Significant Growth

LOS ANGELES- Germany's medical cannabis industry is experiencing substantial growth, driven by recent regulatory reforms and increasing patient demand. Companies such as Cantourage are at the forefront of this expansion, capitalizing on the evolving legal ...

Silo Pharma Initiates Safety Study for PTSD Drug SPC-15

LOS ANGELES- Silo Pharma Inc. a developmental-stage biopharmaceutical company, has commenced a 7-day safety and toxicology study for its lead candidate, SPC-15, an intranasal treatment targeting post-traumatic stress disorder (PTSD). The study is being conducted ...

Subscribe To Our Newsletter

Go to Top